MITRA — Mithra Pharmaceuticals SA Balance Sheet
0.000.00%
Last trade - 00:00
- €15.48m
- €212.36m
- €40.16m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 49.8 | 139 | 32.9 | 28.3 | 8.98 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 25.5 | 60 | 20.3 | 62.6 | 36.1 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 91.5 | 238 | 99.4 | 146 | 93.4 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 94 | 99.5 | 108 | 106 | 51.5 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 398 | 522 | 422 | 442 | 287 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 47.8 | 70.7 | 95.8 | 130 | 104 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 234 | 364 | 388 | 409 | 390 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 163 | 158 | 33.8 | 33.7 | -103 |
Total Liabilities & Shareholders' Equity | 398 | 522 | 422 | 442 | 287 |
Total Common Shares Outstanding |